Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -1.26K | $ -3.75K |
| Operating Income | $ -83.89M | $ -103.70M | $ -161.25M | $ -125.70M | $ -60.84M |
| EBITDA | $ -79.98M | $ 4.91M | $ -157.04M | $ -125.75M | $ -59.45M |
| Net Income | $ -79.98M | $ -98.79M | $ -157.04M | $ -125.75M | $ -59.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.91M | $ 96.32M | $ 148.32M | $ 211.91M | $ 117.09M |
| Total Assets | $ 45.82M | $ 97.55M | $ 152.91M | $ 223.33M | $ 118.19M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.86M | $ -4.09M | $ -5.40M | $ -44.44M | $ -2.50M |
| Total Liabilities | $ 10.30M | $ 12.19M | $ 12.47M | $ 15.06M | $ 12.60M |
| Stockholders' Equity | $ 35.52M | $ 85.36M | $ 140.44M | $ 208.26M | $ 105.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.76M | $ -51.66M | $ -103.80M | $ -91.87M | $ -27.81M |
| Operating Cash Flow | $ -51.76M | $ -51.66M | $ -103.80M | $ -91.87M | $ -27.81M |
| Investing Cash Flow | $ 51.56M | $ 50.45M | $ 19.73M | $ -54.12M | $ -34.45M |
| Financing Cash Flow | $ -40.34K | $ -98.46K | $ 45.02M | $ 187.94M | $ 28.47M |